Literature DB >> 2476114

Human inter-alpha-trypsin inhibitor. Synthesis and maturation in hepatoma HepG2 cells.

J Bourguignon1, R Sesboüé, M Diarra-Mehrpour, M Daveau, J P Martin.   

Abstract

In hepatoma HepG2 cells, human inter-alpha-trypsin inhibitor (ITI) was synthesized as three heavy chains, H-1 (100 kDa), H-2 (110 kDa) and H-3 (113 kDa), and light hybrid chain (49.5 kDa) composed of alpha 1-microglobulin and HI-30 (ITI derivative, human inhibitor of 30 kDa). The association of at least two heavy chains, H-1 and H-3, with the HI-30 part of the light chain gave rise to a molecule similar to serum ITI. A composite protein (approximately 250 kDa) including heavy and light chains was also secreted, while alpha 1-microglobulin and ITI H-2 protein were released as separate entities. Light chain synthesis could be the limiting factor for ITI maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476114      PMCID: PMC1138820          DOI: 10.1042/bj2610305

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Purification of alpha 1-microglobulin produced by human hepatoma cell lines. Biochemical characterization and comparison with alpha 1-microglobulin synthesized by human hepatocytes.

Authors:  C Vincent; M Marceau; P Blangarin; P Bouic; J J Madjar; J P Revillard
Journal:  Eur J Biochem       Date:  1987-06-15

2.  The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC).

Authors:  J F Kaumeyer; J O Polazzi; M P Kotick
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

3.  Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes.

Authors:  M Diarra-Mehrpour; J Bourguignon; R Sesboüé; M G Matteï; E Passage; J P Salier; J P Martin
Journal:  Eur J Biochem       Date:  1989-01-15

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Inter-alpha-trypsin-inhibitor (ITI): two distinct mRNAs in baboon liver argue for a discrete synthesis of ITI and ITI derivatives.

Authors:  J Bourguignon; D Vercaigne; R Sesboüé; J P Martin; J P Salier
Journal:  FEBS Lett       Date:  1983-10-17       Impact factor: 4.124

8.  Identification of the translation products of alpha -1-antitrypsin mRNA from baboon liver polysomes.

Authors:  D Vercaigne; J Bourguignon; F Lefebvre; J P Martin
Journal:  FEBS Lett       Date:  1982-01-25       Impact factor: 4.124

9.  Inter-alpha-trypsin inhibitor (ITI): use of new antisera for qualitative studies and discrete quantitation of ITI and its derivatives.

Authors:  J P Salier; R Sesboüé; D Vercaigne; J Bourguignon; J P Martin
Journal:  Anal Biochem       Date:  1983-09       Impact factor: 3.365

10.  cDNA cloning of human inter-alpha-trypsin inhibitor discloses three different proteins.

Authors:  T Schreitmüller; K Hochstrasser; P W Reisinger; E Wachter; W Gebhard
Journal:  Biol Chem Hoppe Seyler       Date:  1987-08
View more
  2 in total

1.  Post-translational processing of the inter-alpha-trypsin inhibitor in the human hepatoma HepG2 cell line.

Authors:  A Héron; J Bourguignon; A Callé; H Borghi; R Sesboüé; M Diarra-Mehrpour; J P Martin
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

2.  Identification of CTLA2A, DEFB29, WFDC15B, SERPINA1F and MUP19 as Novel Tissue-Specific Secretory Factors in Mouse.

Authors:  Jibin Zhang; Jinsoo Ahn; Yeunsu Suh; Seongsoo Hwang; Michael E Davis; Kichoon Lee
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.